Table 2 Treatment Schedule and Dose
From: A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Treatment Interval (Cycle Length) | No. Patients (%) N = 120* | Median PLD Dose (mg/m2) | PLD Dose Range (mg/m2) |
|---|---|---|---|
2 weeks | 7 (6) | 20 | 15-20 |
3 weeks | 8 (7) | 32 | 27-40 |
4 weeks | 95 (79) | 40 | 20-50 |
5 weeks | 10 (8) | 40 | 30-50 |